BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 6330665)

  • 1. Immunodeficiency as a factor in lymphomagenesis.
    Purtilo DT; Sakamoto K
    Perspect Pediatr Pathol; 1984; 8(2):181-91. PubMed ID: 6330665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients.
    Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S177-81. PubMed ID: 2435295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immune defects to Epstein-Barr virus-determined antigens in young males.
    Masucci MG; Szigeti R; Ernberg I; Masucci G; Klein G; Chessels J; Sieff C; Lie S; Glomstein A; Businco L; Henle W; Henle G; Pearson G; Sakamoto K; Purtilo DT
    Cancer Res; 1981 Nov; 41(11 Pt 1):4284-91. PubMed ID: 6171337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [X-chromosomal recessively inherited lymphoproliferative syndrome. An analysis of EBV-induced immune deficiency].
    Kammermeier-Schmidt U; Weiss M; Belohradsky BH
    Monatsschr Kinderheilkd; 1993 Mar; 141(3):201-6. PubMed ID: 8386321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphotropic viruses, Epstein-Barr virus (EBV) and human T-cell lymphotropic virus-I (HTLV-I)/adult T-cell leukemia virus (ATLV), and HTLV-III/human immune deficiency virus (HIV) as etiological agents of malignant lymphoma and immune deficiency.
    Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S1-6. PubMed ID: 2881552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-linked lymphoproliferative syndrome. An immunodeficiency disorder with acquired agammaglobulinemia, fatal infectious mononucleosis, or malignant lymphoma.
    Purtilo DT
    Arch Pathol Lab Med; 1981 Mar; 105(3):119-21. PubMed ID: 6894075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-linked lymphoproliferative syndrome.
    Sullivan JL; Woda BA
    Immunodefic Rev; 1989; 1(4):325-47. PubMed ID: 2561059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epstein-Barr-virus-induced lymphoproliferative diseases].
    Schuster V; Kreth HW
    Monatsschr Kinderheilkd; 1991 Jul; 139(7):396-400. PubMed ID: 1656248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus-induced diseases in the X-linked lymphoproliferative syndrome and related disorders.
    Purtilo DT
    Biomed Pharmacother; 1985; 39(2):52-8. PubMed ID: 2990590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune deficiency in the X-linked lymphoproliferative syndrome. I. Epstein-Barr virus-specific defects.
    Harada S; Sakamoto K; Seeley JK; Lindsten T; Bechtold T; Yetz J; Rogers G; Pearson G; Purtilo DT
    J Immunol; 1982 Dec; 129(6):2532-5. PubMed ID: 6292290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopathology of the X-linked lymphoproliferative syndrome.
    Purtilo DT
    Haematol Blood Transfus; 1981; 26():207-14. PubMed ID: 6274747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus (EBV) and X-linked lymphoproliferative syndrome (XLP).
    Tatsumi E; Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S109-13. PubMed ID: 3030340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease.
    Grierson HL; Skare J; Hawk J; Pauza M; Purtilo DT
    Am J Med Genet; 1991 Sep; 40(3):294-7. PubMed ID: 1683154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant B-cell lymphoma following and associated with infectious mononucleosis. A comparison of two cases.
    Pattengale PK; Taylor CR; Pegalow C
    Am J Pediatr Hematol Oncol; 1981; 3(1):35-42. PubMed ID: 6263125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus-associated lymphoproliferative syndromes: studies in two European families.
    Schuster V; Dohrmann E; Kreth HW
    Cancer Detect Prev; 1991; 15(1):65-7. PubMed ID: 1646073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization.
    Saemundsen AK; Purtilo DT; Sakamoto K; Sullivan JL; Synnerholm AC; Hanto D; Simmons R; Anvret M; Collins R; Klein G
    Cancer Res; 1981 Nov; 41(11 Pt 1):4237-42. PubMed ID: 6272968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-linked lymphoproliferative syndrome provides clues to the pathogenesis of Epstein-Barr virus-induced lymphomagenesis.
    Purtilo DT; Yasuda N; Grierson HL; Okano M; Brichacek B; Davis J
    Princess Takamatsu Symp; 1987; 18():149-58. PubMed ID: 2852188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency.
    Sullivan JL; Byron KS; Brewster FE; Baker SM; Ochs HD
    J Clin Invest; 1983 Jun; 71(6):1765-78. PubMed ID: 6306053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients.
    Purtilo DT; Tatsumi E; Manolov G; Manolova Y; Harada S; Lipscomb H; Krueger G
    Int Rev Exp Pathol; 1985; 27():113-83. PubMed ID: 3017882
    [No Abstract]   [Full Text] [Related]  

  • 20. Epstein-Barr virus and the X-linked lymphoproliferative syndrome.
    Sullivan JL
    Adv Pediatr; 1983; 30():365-99. PubMed ID: 6324556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.